Lockdown skin cancer diagnosis delays linked to deaths and £6bn costs in Europe
Delays in diagnosing melanoma due to COVID-19 lockdown may have contributed to over 100,000 years of life lost across Europe and over £6bn in costs, mainly indirectly due to loss of productivity, finds a new study led by ...
Feb 16, 2024
0
0